Skip to content

Electrophysiological mechanisms of psychedelic drugs: A systematic review.

Javier Hidalgo Jiménez, Karl Kristjan Kaup, Jaan Aru

Neuroscience & Biobehavioral Reviews June 1, 2026 DOI: 10.1016/j.neubiorev.2026.106649 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review Peer reviewed
Topics LSD
Keywords 5-ht2a Doi Electrophysiology Nboh Psychedelics
Citations 1
Key findings Psychedelics modulate both excitatory and inhibitory processes in a cell-type- and compartment-specific manner, challenging the simplified view that they uniformly increase cortical excitability.

Abstract

Serotonergic psychedelics are known for their profound effects on consciousness and are gaining renewed interest as potential psychiatric treatments. These advances underscore the need to clarify the mechanisms of action of these compounds. This systematic review compiles and critically evaluates 23 in vitro and 26 in vivo electrophysiological studies on psychedelic compounds, with an emphasis on layer 5 pyramidal neurons in the prefrontal cortex, where 5-HT2A receptors are densely expressed. Our findings reveal that psychedelics exert complex, heterogeneous effects on neuronal excitability, synaptic transmission, and local oscillations. These results challenge the simplified view that psychedelics uniformly increase cortical excitability. Instead, they modulate both excitatory and inhibitory processes in a cell-type- and compartment-specific manner, with evidence for biphasic, dose-dependent, and context-sensitive responses. Activation of 5-HT2A receptors leads to intricate calcium signaling, downregulating excitatory currents and firing rates in many neurons, while enhancing glutamate release and activating a subset of projection fibers. Modulation of presynaptic and extrasynaptic GluN2B-containing NMDA receptors appears central to these effects, and some indirect evidence supports the involvement of intracellular 5-HT2A receptors. These insights prompt a reassessment of prevailing models of psychedelic action and underscore the value of incorporating electrophysiological data into psychedelic neuropharmacology.

Comparable studies

Other systematic reviews and meta-analyses on LSD, most cited first.

Study Year Design Participants
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials Participants in randomized controlled trials of LSD for alcoholism 2012 Meta-analysis n = 536
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years Patients from included clinical trials 2016 Systematic review
Default Mode Network Modulation by Psychedelics: A Systematic Review Participants from included studies 2022 Systematic review
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews Patients with mood, anxiety, or substance-use disorders, including cancer patients and... 2018 Systematic review of systematic reviews
Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials Patients with psychiatric disorders, primarily alcoholism 2020 Systematic review n = 567

Citations in the library

Explore topics